Patients News | pharmaphorum

News

FDA seeks feedback on digital tools for diabetes

The FDA has opened a comment period, extending until the end of the month, that is seeking information on how digital health technologies (DHTs) might be deployed to help

News

FDA finds no link between GLP-1 drugs and suicide

The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide, saying it can find no evid

News

NICE expands access to Paxlovid amid over-supply

NICE has extended the number of patients eligible for treatment with Pfizer’s oral antiviral Paxlovid by around 1.4 million, as millions of doses of the COVID-19 therapy a

News

FDA clears French syphilis drug imports to tackle shortage

Facing a sharp rise in the number of syphilis cases, the FDA has authorised the importation from France of a life-saving drug for the sexually transmitted infection (STI)

News

JPM: Amazon, Omada launch digital health benefits alliance

Amazon has launched a health monitoring programme in partnership with Omada Health that aims to identify people who may be eligible for enrolment into the latter’s disease

News

Novo Nordisk Foundation puts $25m into AMR programme

The Novo Nordisk Foundation has come up with more funding to help battle the scourge of antimicrobial resistance (AMR), putting $25 million into a non-profit accelerator programme hun

FDA seeks feedback on digital tools for diabetes

FDA finds no link between GLP-1 drugs and suicide

NICE expands access to Paxlovid amid over-supply

FDA clears French syphilis drug imports to tackle shortage

JPM: Amazon, Omada launch digital health benefits alliance

Novo Nordisk Foundation puts $25m into AMR programme

Ultragenyx to slash costs after Angelman trial failure

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks